Article | September 14, 2022

Why You Need To Engage DCT Study Vendors Earlier To Assist In Designing Decentralized Clinical Trials

Source: Curebase
Cell phone clinical trial patient form COA

There are several ways to incorporate decentralized components into clinical trials that can leverage specific solutions to create decentralized clinical trials (DCTs) or fully virtual clinical trials (sometimes called siteless trials) from the original protocol. This can be done through the incorporation of wearables and other technology, ePRO software, eConsent software, remote sample collections or drug distribution, telehealth capabilities, and much more. The key, however, to successfully running a decentralized clinical trial is being able to incorporate these components seamlessly and with as little additional cost and burden as possible. 

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader